Ginsenoside Rh2 reduces ischemic brain injury in rats

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 3, 2004, Pages 433-436

  Park, Eun Kyung ^a   Choo, Min Kyung ^a   Oh, Jin Kyung ^a   Ryu, Jong Hoon ^a   Kim, Dong Hyun ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Ginseng; Ginsenoside Rh2; Intestinal bacteria; Ischemia; Prostaglandin E 2

Indexed keywords

GINSENG EXTRACT; GINSENOSID RG3; GINSENOSIDE RH 2; HYDROCHLORIC ACID; LIPOPOLYSACCHARIDE; NEUROPROTECTIVE AGENT; PROSTAGLANDIN E2; PROTOPANAXADIOL; SAPONIN; UNCLASSIFIED DRUG; GINSENOSIDE; HERBACEOUS AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; GINSENG; INTESTINE FLORA; MALE; NEUROPROTECTION; NONHUMAN; RAT; REPERFUSION INJURY; ANIMAL; CELL CULTURE; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; FECES; HUMAN; INTESTINE; METABOLISM; MICROBIOLOGY; MOUSE; ORAL DRUG ADMINISTRATION; PHYTOTHERAPY; PLANT ROOT; SPRAGUE DAWLEY RAT;

ADMINISTRATION, ORAL; ANIMALS; CELLS, CULTURED; DRUGS, CHINESE HERBAL; FECES; GINSENOSIDES; HUMANS; HYDROCHLORIC ACID; INTESTINES; MALE; MICE; PANAX; PHYTOTHERAPY; PLANT ROOTS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 4544352951     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.433     Document Type: Article

References (17)

1. Shibata S., Fujita M., Itokawa H., Tanaka O., Ishii T., Chem. Pharm. Bull., 11, 759-764 (1963).
2. Tanaka N., Tanaka O., Shibata S., Chem. Pharm. Bull., 20, 1212-1216 (1972).
3. Kitagawa I., Yoshikawa M., Yoshihara M., Hayashi T., Taniyama T., Yakugaku Zasshi, 103, 612-622 (1983).
4. Han B. H., Park M. H., Han Y. N., Woo L. K., Sankawa U., Yahara S., Tanaka O., Planta Med., 44, 146-149 (1982).
5. Bae E. A., Han M. J., Choo M. K., Park S. Y., Kim D.-H., Biol. Pharm. Bull., 25, 58-63 (2002).
6. Wu J. Y., Gardner B. H., Murphy C. I., Seals J. R., Kensil C. R., Recchia J., Beltz G. A., Newman G. W., Newman M. J., J. Immunol., 148, 1519-1525 (1992).
7. Sato K., Mochizuki M., Saiki I., Yoo Y. C., Samukawa K., Azuma I., Biol. Pharm. Bull., 17, 635-639 (1994).
8. Mochizuki M., Yoo C. Y., Matsuzawa K., Sato K., Saiki I., Tono-oka S., Samukawa K., Azuma I., Biol. Pharm. Bull., 18, 1197-1202 (1995).
9. Akao T., Kanaoka M., Kobashi K., Biol. Pharm. Bull., 21, 245-249 (1998).
10. Akao T., Kida H., Kanaoka M., Hattori M., Kobashi K., J. Pharm. Pharmacol., 50, 1155-1160 (1998).
11. Kanaoka M., Kato H., Shimada F., Yano S., Chem. Pharm. Bull., 40, 314-317 (1992).
12. Kanaoka M., Akao T., Kobashi K., J. Trad. Med., 11, 241-245 (1994).
13. Wakabayashi C., Hasegawa H., Murata J., Saiki I., Oncol. Res., 9, 411-417 (1998).
14. Bae E. A., Park S. Y., Kim D.-H., Biol. Pharm. Bull., 23, 1481-1485 (2000).
15. Hattori M., Shu Y.-Z., Shimizu M., Hayashi T., Morita N., Kobashi K., Xu G.-J., Namba T., Chem. Pharm. Bull., 33, 3838-3846 (1985).
16. Nagasawa H., Kogure K., Stroke, 20, 1037-1043 (1989).
17. Yuan C. S., Attele A. S., Wu J. A., Liu D., J. Ethnopharmacol., 62, 215-222 (1998).